PIRAMAL PHARMA
Back to Balance Sheet
|
PIRAMAL PHARMA Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹96 Cr | ₹100 Cr | ₹61 Cr | ₹57 Cr | ₹45 Cr |
What is the latest Contingent Liabilities ratio of PIRAMAL PHARMA ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹96 Cr |
| Mar2025 | ₹100 Cr |
| Mar2024 | ₹61 Cr |
| Mar2023 | ₹57 Cr |
| Mar2022 | ₹45 Cr |
How is Contingent Liabilities of PIRAMAL PHARMA Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹96 Cr | -4.05 | |
| Mar2025 | ₹100 Cr | 62.40 | |
| Mar2024 | ₹61 Cr | 7.17 | |
| Mar2023 | ₹57 Cr | 27.55 | |
| Mar2022 | ₹45 Cr | - | |
Compare Contingent Liabilities of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹27,258.4 Cr | -4.4% | 14% | 8.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,675.0 Cr | -3% | -2.6% | 21.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,516.0 Cr | -0.5% | 17% | 43.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,190.0 Cr | 0.6% | 2.7% | 35.5% | Stock Analytics | |
| CIPLA | ₹115,523.0 Cr | -2.2% | 0.8% | -2.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,493.4 Cr | -1.1% | -1.6% | -0.8% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | -4.4% |
14% |
8.7% |
| SENSEX | -1% |
0.7% |
-3.6% |
You may also like the below Video Courses